rs73139245
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001378609.3(OTOGL):c.5923T>C(p.Leu1975Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0054 in 1,593,886 control chromosomes in the GnomAD database, including 33 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001378609.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 84BInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
- nonsyndromic genetic hearing lossInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| OTOGL | NM_001378609.3 | c.5923T>C | p.Leu1975Leu | synonymous_variant | Exon 49 of 59 | ENST00000547103.7 | NP_001365538.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00523 AC: 795AN: 152106Hom.: 5 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.00566 AC: 1318AN: 232748 AF XY: 0.00576 show subpopulations
GnomAD4 exome AF: 0.00542 AC: 7814AN: 1441662Hom.: 28 Cov.: 29 AF XY: 0.00544 AC XY: 3896AN XY: 716728 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00522 AC: 794AN: 152224Hom.: 5 Cov.: 32 AF XY: 0.00575 AC XY: 428AN XY: 74420 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Benign:4
- -
- -
- -
OTOGL: BP4, BP7, BS2 -
not specified Benign:1
Leu1966Leu in exon 48 of OTOGL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 0.5% (44/8600) of European American chromosomes from a broad population by the NHLBI Exome Sequenc ing Project (http://evs.gs.washington.edu/EVS; dbSNP rs73139245). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at